The Case of the Sticky Protein
News Dec 21, 2015
Proteins are like a body's in-house Lego set. These large, complex molecules are made up of building blocks called amino acids. Most of the time, proteins fold correctly, but sometimes they can misfold. This misfolding causes the proteins to get sticky, and that can promote clumping, or aggregation, which is the hallmark of several neurodegenerative diseases such as ALS, Alzheimer's and Parkinson's.
The protein's stickiness is a result of surface hydrophobic interactions that are important for many biological functions. The problem is that researchers don't have good tools to measure this stickiness with high sensitivity.
Now, an interdisciplinary team at Michigan Technological University has assembled new tools to solve the case of the sticky protein.
Using the fluorescent probes, the team measured hydrophobicity in three proteins: Bovine Serum Albumin (BSA), apomyoglobin and myoglobin. Compared to a commonly used commercial sensor (ANS), these new BODIPY-based hydrophobic sensors showed much stronger signal strengths, with up to a 60-fold increase in BSA.
"This is like going from having one 40-watt light bulb and then having 60 of them in the same room, just imagine the difference in illumination," says Ashutosh Tiwari, an associate professor of chemistry at Michigan Tech and the corresponding author for the study.
The spatial and temporal dynamics of proteins or organelles plays a crucial role in controlling various cellular processes and in development of diseases. However, acute control of activity at distinct locations within a cell cannot be achieved. A new chemo-optogenetic method enables tunable, reversible, and rapid control of activity at multiple subcellular compartments within a living cell.
Scientists from the UNC School of Medicine discovered that the anti-inflammatory protein NLRP12 normally helps protect mice against obesity and insulin resistance when they are fed a high-fat diet. The researchers also reported that the NLRP12 gene is underactive in people who are obese, making it a potential therapeutic target for treating obesity and diabetes.READ MORE